Epidural Top-up: Which Local Anesthetic Should You Choose?

A pregnant woman in labor is suddenly told she needs an emergency cesarean section. Do you top up through the indwelling ...
BIOENGINEER

Anesthesia Breakthrough Helps Surgeons Rebuild the Superior Vena Cava in Thymic Tumor Surgery

Anesthesiologists at Zhongshan Hospital have developed a detailed protocol that makes extended thymic tumor resection with ...
BIOENGINEER

Lying Patients Face-Down Raises Brain Pressure Only Slightly, Major Review Finds

A new systematic review and meta-analysis finds that prone positioning in brain-injured intensive care patients causes only a ...

Charlie Forde Promises A Receipt For Every Payment As She Raises $15,000 To Feed Rescued Animals At A Canadian Sanctuary

Australian veterinarian Charlie Forde worked for four years as an emergency vet in her home country before moving to Los ...
Public Broadcasting Service (PBS)

Pediatric Spinal Problems: It's More Than Scoliosis

Pediatric orthopedic spine surgeon Kelly A. Jenkins, M.D., discusses pediatric spinal conditions, including the diagnosis and ...
news.laodong

8 new operating rooms, solving the problem of wastefulness at Quang Nam General Hospital

8 modern operating rooms officially operated, making an important contribution to the nearly 179 billion VND High-Tech ...
The Cardiology Advisor

Updated Guidelines for Perioperative Cardiovascular Management

Updated clinical practice guidelines outline new protocols for cardiovascular risk assessment and medical therapy prior to noncardiac surgery.

U.S. Ambulatory Surgery Center Market Reaches $49.19 Billion in 2026 as Outpatient Procedure Migration, Higher-Acuity Cases and ASC Consolidation Reshape U.S. Sur…

The U.S. ambulatory surgery center (ASC) market is entering a significant phase of expansion as healthcare providers, ...
MarketScreener

Medtronic plc Presents 24-Month Exploratory Analysis from Titan 2 Pivotal Clinical Trial Showing Sustained Reductions in Nocturia Episodes for Altaviva Device

Medtronic plc announced new clinical evidence and program updates for the Altaviva? implantable tibial neuromodulation device at AUGS 2026, highlighting continued momentum following the device's U.S.